Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-005505
Filing Date
2025-03-14
Accepted
2025-03-14 17:43:00
Documents
2
Period of Report
2025-03-13

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3950
2 K. PETERSON POA exhibit24-1.txt EX-24.1 3246
  Complete submission text file 0001062993-25-005505.txt   8645
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address AMARIN CORPORATION MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE MYSTIC CT 06355
Business Address
Peterson Kristine (Reporting) CIK: 0001508596 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 25741529